Jones Financial Companies
GMAB icon

Jones Financial Companies’s Genmab GMAB Stock Holding History

Jones Financial Companies’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$134K Buy
5,126
+435
+9% +$11.6K ﹤0.01% 2739
2026
Q1 		$121K Buy
4,691
+2,847
+154% +$85.3K ﹤0.01% 2599
2025
Q4 		$56.8K Sell
1,844
-107
-5% -$3.33K ﹤0.01% 2457
2025
Q3 		$56.8K Buy
1,951
+440
+29% +$10.7K ﹤0.01% 2328
2025
Q2 		$31K Buy
1,511
+183
+14% +$3.76K ﹤0.01% 2413
2025
Q1 		$26.4K Buy
1,328
+849
+177% +$17.8K ﹤0.01% 2324
2024
Q4 		$10K Buy
479
+79
+20% +$1.74K ﹤0.01% 2526
2024
Q3 		$9.73K Buy
400
+111
+38% +$2.97K ﹤0.01% 2217
2024
Q2 		$7.26K Buy
+289
New +$8.19K ﹤0.01% 1856
2024
Q1 		– Sell
-9
Closed -$287 – 1405
2023
Q4 		$287 Buy
+9
New +$283 ﹤0.01% 1001
2022
Q1 		– Sell
-96
Closed -$4K – 743
2021
Q4 		$4K Buy
+96
New +$4K ﹤0.01% 662

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Jones Financial Companies's GMAB Position: Q2 2026 in Review

Jones Financial Companies increased its Genmab (GMAB) stake by 9.3% in Q2 2026, buying an estimated $11.6K and bringing the position to 5,126 shares worth $134K. The position accounts for ﹤0.01% of the portfolio, ranked #2739.

Jones Financial Companies first reported a position in GMAB in Q4 2021 and has held it in 11 quarters since. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Jones Financial Companies held 5,126 shares of Genmab worth $134K as of Q2 2026.
  • Jones Financial Companies bought 435 Genmab shares in Q2 2026, an estimated $11.6K.
  • Genmab made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #2739 holding.
  • Jones Financial Companies first reported a position in Genmab in Q4 2021 and has held it in 11 quarters since.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.